Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects

NCT04821674 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: DS-5670a
BIOLOGICAL: Placebo

Sponsor

Daiichi Sankyo Co., Ltd.